Wed, Feb 26, 10:15 PM (58 days ago)
**Alphatec Holdings, Inc. (ATEC) 10-K Summary for FY 2024** Alphatec Holdings, Inc. reported a revenue of $611.6 million for FY 2024, marking a 27% increase from $482.3 million in FY 2023. This growth was driven by rising surgeon adoption of its spine surgery technologies. The net loss for the year was $162.1 million, compared to a loss of $186.6 million the previous year. Operating expenses rose to $560.4 million, largely due to increased sales and administrative costs. The company aims to maintain its market position by focusing on innovative spine treatment solutions and expanding its sales network. Future outlook remains positive, but risks include competition from larger firms and reliance on third-party suppliers. Alphatec's total assets were valued at $775.7 million, with cash and cash equivalents at $138.8 million. Significant debt includes $200 million under the Braidwell Term Loan and $316.3 million in convertible notes due 2026. The company has a history of net losses, with an accumulated deficit of $1.3 billion as of year-end. Overall, Alphatec is positioned for growth but faces challenges in profitability and market competition.